FindTrial
Sign In

Thromboelastography combined with blood coagulation test to guide the optimal blood transfusion treatment in liver cirrhosis patients complicated by acute upper gastrointestinal bleeding

Thromboelastography combined with blood coagulation test to guide the optimal blood transfusion treatment in liver cirrhosis patients complicated by acute upper gastrointestinal bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036321
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Optimized group:Take TEG test based on routinal examinations
control group:Routinal examination such as coagulation test

Sponsors

People's Hospital of Chongqing Hechuan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Conforming to the diagnostic criteria of liver cirrhosis and acute upper gastrointestinal bleeding.

Exclusion criteria

Exclusion criteria: (1) In the case of inability to match, the patients complicated with blood transfusion reaction due to incompatibility of white blood cell and platelet HLA, or allergy to a certain component in the donor's plasma; (2) the patients with various immune diseases due to anti-red blood cell antibodies or complement in plasma which can damage red blood cells and cause hemolysis; (3) the patients with uremia, hyperkalemia and acidosis.

Design outcomes

Primary

MeasureTime frame
the component ratio and total volume of blood products;—

Countries

China

Contacts

Public ContactQiu Qiu

People's Hospital of Chongqing Hechuan

3608945442@qq.com+86 13452932965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026